1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Graves Orbitopathy: new trials by email Literature Review of Graves Orbitopathy trials Research Report on Graves Orbitopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) Linsitinib, Placebo - Thyroid Eye Disease, Graves Orbitopathy | Phase 2 / Phase 3 | Completed | Sling Therapeutics, Inc. | 90 | 2022-07-01 | 2026-09-23 |
Endocrine System Diseases (1) · Exophthalmos (1) · Eye Diseases (1) · Graves Ophthalmopathy (1) · Hashimoto Disease (1) · Orbital Diseases (1) · Thyroid Diseases (1)
Autoimmune Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1) · Goiter (1) · Graves Disease (1) · Hyperthyroidism (1) · Immune System Diseases (1) · Thyroiditis (1) · Thyroiditis, Autoimmune (1)
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol (1)
Canada (1) · Italy (1) · Spain (1) · United Kingdom (1) · United States (1)